The future of US psychedelic medicine is carved out by the FDA

The US Food and Drug Administration (FDA) has issued its first comprehensive guidance on how psychedelic drugs should best be studied in clinical trials, signalling a shift toward recognizing the potential of these therapeutics. The report also outlines what's needed to see...